Dr. Han's clinical interests focus on treatment of recurrent skin and soft-tissue infections (SSTIs), including those due to MRSA.
Dr. Han's research focuses on healthcare-associated infections, antibiotic resistance, and antibiotic use, with a focus on infections due to multidrug-resistant organisms across inter-related healthcare settings (e.g., post-acute care).
Han JH, Nachamkin I, Tolomeo P, Mao X, Bilker WB, Lautenbach E. : Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones. Diagnostic Microbiology and Infectious Diseases 76(4): 491-6, August 2013.
Han JH, Bilker WB, Nachamkin I, Tolomeo P, Mao X, Fishman NO, Lautenbach E. : Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility. Infection Control and Hospital Epidemiology 34(10): 1070-6, October 2013.
Han JH, Edelstein PH, Bilker WB, Lautenbach E: The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia. The Journal of Infection 66(1): 41-7, Jan 2013.
Han JH, Bilker WB, Edelstein PH, Mascitti KB, Lautenbach E: Derivation and validation of clinical prediction rules for reduced vancomycin susceptibility in Staphylococcus aureus bacteraemia. Epidemiology and Infection 141(1): 165-73, Jan 2013.
Greenblatt RM, Han JH, Nachamkin I, Tolomeo P, Lautenbach E: Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions. Infection Control and Hospital Epidemiology 34(1): 40-8, Jan 2013.
Han JH, Nachamkin I, Tolomeo P, Bilker WB, Lautenbach E: Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli. The Journal of Infectious Diseases 206(10): 1597-603, Nov 2012.
Han JH, Nachamkin I, Zaoutis TE, Coffin SE, Linkin DR, Fishman NO, Weiner MG, Hu B, Tolomeo P, Lautenbach E: Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infection Control and Hospital Epidemiology 33(12): 1242-5, Dec 2012.
Han JH, Kasahara K, Edelstein PH, Bilker WB, Lautenbach E: Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli. Antimicrobial Agents and Chemotherapy 56(11): 5575-80, Nov 2012.
Han JH, Crane HM, Bellamy SL, Frank I, Cardillo S, Bisson GP, on behalf of the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS): HIV infection and glycemic response to newly initiated diabetic medical therapy. AIDS (London, England) 26(16): 2087-95, Oct 2012.
Han JH, Mascitti KB, Edelstein PH, Bilker WB, Lautenbach E: Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy 56(10): 5164-70, Oct 2012.
Han JH, Edelstein PH, Lautenbach E: Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia. The Journal of Antimicrobial Chemotherapy 67(10): 2346-9, Oct 2012.
Lautenbach E, Han JH, Santana E, Tolomeo P, Bilker WB, Maslow J. : Colonization with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in long-term care facility residents. Infection Control and Hospital Epidemiology 33(3): 302-4, March 2012.
back to top
Last updated: 10/31/2013
The Trustees of the University of Pennsylvania